Given that obesity increases AHR early in the time course7 and that anakinra was administered only during last two weeks of the 8-week experiment, our data suggest that IL-1β receptor blockers not merely prevent, but also reverse obese asthma. The gene discussed is AHR; the disease is obesity due to melanocortin 4 receptor deficiency.